We believe that with the current Pan-Cancer Analysis of Whole Genomes (PCAWG) project involving classic glioma microenvironment biomarkers (i.e., IDH1), researchers will identify more specialized features of cancer immune genomes (59). The gene discussed is IDH1; the disease is glioma.